Wealth Enhancement Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Wealth Enhancement Advisory Services's AMRX Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Amneal Pharmaceuticals (AMRX) stake by 2.1% in Q3 2026, buying an estimated $22.4K and bringing the position to 60,365 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #3091.
Wealth Enhancement Advisory Services first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Wealth Enhancement Advisory Services held 60,365 shares of Amneal Pharmaceuticals worth $385K as of Q3 2026.
- Wealth Enhancement Advisory Services bought 1,242 Amneal Pharmaceuticals shares in Q3 2026, an estimated $22.4K.
- Amneal Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3091 holding.
- Wealth Enhancement Advisory Services first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.